154650-59-6

Basic information

• Product Name: 2-broMo-4,6-difluorobenzaldehyde
• Synonyms: 2-broMo-4,6-difluorobenzaldehyde
• CAS NO: 154650-59-6
• Molecular Formula: C₇H₃BrF₂O
• Molecular Weight: 220.9989264
• Mol File: 154650-59-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 225.1±35.0 °C(Predicted)
• Appearance: /
• Density: 1.758±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-broMo-4,6-difluorobenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-broMo-4,6-difluorobenzaldehyde(154650-59-6)
• EPA Substance Registry System: 2-broMo-4,6-difluorobenzaldehyde(154650-59-6)

Safety Data

• Hazardous Substances Data: 154650-59-6(Hazardous Substances Data)

Usage

General Description

2-Bromo-4,6-difluorobenzaldehyde is a chemical compound with the molecular formula C7H3BrF2O. It is an aromatic aldehyde with a bromine and two fluorine atoms attached to a benzene ring. 2-broMo-4,6-difluorobenzaldehyde is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also used in the production of dyes and other organic compounds. 2-Bromo-4,6-difluorobenzaldehyde has potential applications in medicinal chemistry and material science due to its unique chemical properties and reactivity. However, it is important to handle this compound with caution as it can be hazardous if not properly managed.

Upstream product

• 59142-68-6 2-bromo-4-fluorobenzaldehyde 
• 4394-85-8 4-morpholinecarboxaldehyde 
• 175278-11-2 1-bromo-3,5-difluoro-2-iodobenzene 

Downstream Products

• 1807071-21-1 (2-bromo-4,6-difluorophenyl)methanol 
• 1337606-50-4 2-bromo-4,6-difluorobenzonitrile 

Relevant articles and documents

BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; (I) a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.

(Aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use

The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the compounds for use alone or in combinations in a method for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of acute and recurrent bleeding in patients with or without underlying hereditary or acquired bleeding disorders, wherein the bleeding is associated with a disease or medical intervention selected from the group consisting of menorrhagia, postpartum hemorrhage, hemorrhagic shock, trauma, surgery, transplantation, stroke, liver diseases, hereditary angioedema, nosebleed, and synovitis and cartilage damage following hemarthrosis.